On-Demand Webcast

Share

Program Content

Activities

  • BTK inhibitors in CLL
    Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2021

    Expires: July 18, 2022

Faculty

cover img faculity

George Follows, BM, BCh, PhD

Visiting Professor of Haematology
Department of Haematology
Anglia Ruskin Medical School
Consultant Haematologist
Department of Haematology
Cambridge University Hospitals
Cambridge, United Kingdom

cover img faculity

Paolo Ghia, MD, PhD

Professor of Medical Oncology
Division of Experimental Oncology
Università Vita-Salute San Raffaele
Milan, Italy

cover img faculity

Veronique Leblond, MD

Professor, Hematology
Sorbonne University
Head, Department of Hematology
Pitié Salpêtrière Hospital
Paris, France

Provided by

ProCE Banner

Supporters

AstraZeneca